| 康诺亚生物医药科技有限公司, 02162.HK - 盈利摘要 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
| 盈利(百万) |
-348 |
-4,760 |
-976 |
-187 |
| 盈利增长(%) |
92.7 |
-387.87 |
-421.21 |
0.0 |
| 每股盈利(港元) |
-1.3312 |
-29.5962 |
-14.5412 |
0.0 |
| 每股盈利增长(%) |
95.5 |
-103.53 |
0.0 |
0.0 |
| 每股派息(港元) |
0.0 |
0.0 |
0.0 |
0.0 |
| 市盈率(倍) |
-46.65 |
-2.18 |
-2.25 |
0.0 |
| 周息率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
| 派息比率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
| 每股账面资产净值 |
13.4705 |
15.9816 |
-6.1325 |
0.0 |
| 报告货币 |
港元 |
港元 |
港元 |
港元 |
| 基准货币 |
港元 |
港元 |
港元 |
港元 |
| 兑换比率 |
1.1281 |
1.2245 |
1.1919 |
1.1175 |
说明：兑换比率资料来源于香港金融管理局《金融资料月报》
|
We've noticed you're using an ad blocker
We spend millions of dollars each year so you can access, for FREE, the highest quality real-time quotes and charts. This is made possible only thanks to the advertising on our site.
To continue using 88iv.com, please allow this domain on your ad blocker.
We are thanksful for your decisive action.
This notice will be shown again every hour.
Close This Window